Effectiveness of Periodontitis Treatment on the Metabolic Activity of Symptomatic Carotid Atherosclerotic Plaque Responsible for Ischemic Stroke
NCT06484036 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 157
Last updated 2024-07-03
Summary
Cardiovascular disease is the world's leading cause of death. Atherothrombosis is a common cause of ischemic stroke.
A strong epidemiological link has been established between periodontitis and the risk of stroke. It shares common risk factors with atherothrombosis, and its severe form is associated with low-grade systemic inflammation and daily low-intensity bacteremia. Atherothrombosis is a frequent cause of ischemic stroke.
Periodontal bacteria have been found within atheromatous plaques, correlated with a greater risk of rupture.
Thus, periodontitis could be a modifiable risk factor for atherothrombosis and future vascular events: its early diagnosis and treatment could have a major impact on cardiovascular prevention.
Hypothesis: In patients with periodontitis who have had an ischemic stroke, periodontal treatment may reduce atherosclerotic plaque activity.
Conditions
- Severe Periodontitis
- Ischemic Stroke
Interventions
- PROCEDURE
-
periodontal treatment strategy
Periodontal treatment sessions (Experimental Group only) (1 to 3 months) after randomization
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-01
- Primary Completion
- 2028-03-01
- Completion
- 2028-09-01
More Related Trials
-
Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial
NCT07295366 ·Status: COMPLETED ·Phase: PHASE4
-
EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)
NCT06138834 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Monosialoganglioside in Acute Ischemic Stroke: a Randomized, Blinded and Multicenter Confirmatory Study
NCT06742216 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke
NCT03252626 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke
NCT07040085 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia
NCT07202143 ·Status: RECRUITING ·Phase: PHASE3
-
A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke
NCT02152280 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of BIIB131 for Participants With Ischemic Stroke Between 4.5 and 24 Hours After Last Known Well
NCT05764122 ·Status: WITHDRAWN ·Phase: PHASE2
-
Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets in Small Vessel Disease
NCT06674460 ·Status: RECRUITING ·Phase: PHASE3
-
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
NCT06841978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Oral DLBS1033 as Adjunctive Therapy in Acute Ischemic Stroke: Impact on Inflammatory Biomarkers and Outcomes
NCT07121569 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke
NCT07301372 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements
NCT02961504 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effectiveness of Yangxue Qingnao Granules in Preventing Post Thrombolytic Hemorrhage Transformation in Patients With Acute Cerebral Infarction
NCT06344312 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
NCT02430350 ·Status: COMPLETED ·Phase: PHASE3
-
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
NCT03578822 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of TTYP01 Tablets in the Treatment of Acute Ischemic Stroke
NCT06648304 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours
NCT01221246 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke
NCT06134635 ·Status: NOT_YET_RECRUITING
-
The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke
NCT05663307 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Endovascular Therapy for Acute Ischemic Stroke Trial
NCT02350283 ·Status: COMPLETED ·Phase: PHASE3
-
Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke
NCT02643784 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of High and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcome in Patients With AIS
NCT03402204 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
NCT00272909 ·Status: TERMINATED ·Phase: PHASE2
-
STROKE 120 ACTION Trial
NCT07135310 ·Status: NOT_YET_RECRUITING ·Phase: NA